SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): January 27, 2004
Commission file number 1-12215
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, NJ 07608
(201) 393-5000
Delaware
(State of Incorporation)
16-1387862
(I.R.S. Employer Identification Number)
Item 7. Financial Statements and Exhibits
c. Exhibit
99.1 Press release of Quest Diagnostics Incorporated dated January 27, 2004
announcing, among other things, its results for the quarter and year
ended December 31, 2003.
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 9, "Regulation FD
Disclosure" and Item 12, "Results of Operations and Financial Condition." On
January 27, 2004, Quest Diagnostics Incorporated issued a press release
announcing, among other things, its results for the quarter and year
ended December 31, 2003. A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated by reference herein.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
January 27, 2004
QUEST DIAGNOSTICS INCORPORATED
By: /s/ Robert A. Hagemann
------------------------------
Robert A. Hagemann
Senior Vice President and
Chief Financial Officer